Improving Return on Investment in Pharmaceutical MarketingDecision ResourcesJune 17, 2008 28 Pages - SKU: DECR1812803 |
|
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
4/20/2012 | published by: GBI Research
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs Summary GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations
|
more...
|
$3,500.00
|
|
2012 CMO Tech Marketing Barometer Study: Trends, Forecast, and Essential Guidance for Tech Marketing Executives
4/25/2012 | published by: IDC
This IDC study discusses IDC's 2012 CMO Tech Marketing Barometer Survey, which analyzes the level and direction of overall tech marketing spend to help guide IDC clients in their marketing investment and allocation decisions. In
|
more...
|
$4,500.00
|
|
2012 Global Diagnostic Imaging Companies Marketing Tactics
4/19/2012 | published by: Venture Planning Group
For each company, the analysis presents: The U.S. and international sales force size in major geographic regions. Selling options, including rental plans, leasing and others. Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System
|
more...
|
$2,500.00
|
|
The 2012 Leading Paint and Coatings Companies Marketing Tactics
3/28/2012 | published by: Venture Planning Group
For each company, the report presents: Promotional tactics. Distribution approaches. Product service and support. Customer relations. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and
|
more...
|
$1,850.00
|
|
The 2012 Leading Flavor and Fragrance Companies Marketing Capabilities
3/28/2012 | published by: Venture Planning Group
For each company, the analysis presents: Sales force in the U.S. and other international markets. Major sale office locations. Distribution strategies. Major promotional tactics. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise,
|
more...
|
$1,850.00
|
|
Patient Adherence and Compliance: Improving Outcomes through Patient Engagement Programs
3/1/2012 | published by: Cutting Edge Information
Drive Patient Adherence and Compliance
Low adherence and compliance is a problem that plagues not only life science companies but also whole health systems, including patients who suffer needlessly and payers who fall short
|
more...
|
$7,695.00
|
|
Understanding Regional Chinese Health Markets
3/15/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data.
|
more...
|
$690.00
|
|
Pharmaceutical Contract Manufacturing
3/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Million by the following Dosage Forms: Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid Dosage Forms (Syrups
|
more...
|
$4,500.00
|
|
The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders
3/1/2012 | published by: CBR Pharma Insights, LLC
Pharmaceuticals save lives. They prevent more serious, life changing conditions, they prevent surgery, and they improve the quality of life for many patients. The environment in which these products are developed and
|
more...
|
$3,900.00
|
|
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
3/9/2012 | published by: iCD Research
Synopsis
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been
|
more...
|
$2,000.00
|
Related Markets
General Pharmaceuticals Reports
- Perspective: TAKE Solutions Gives Leading Pharma an Edge in Drug Serialization
- Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
- The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
- Patient Adherence and Compliance: Improving Outcomes through Patient Engagement Programs
- The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders
